Esperion stock rises after Japan approves cholesterol drug NEXLETOL

I’m revisiting a piece I wrote in January 2026: “Following the Smart Money: Service Stocks Lead the Way.” The reason for that: we were looking at a beaten-down sector and doubling down on our conviction on why it could be close to a turning point. But even more specifically, we were looking at oil and…

Vale (NYSE:VALE – Get Free Report) issued its quarterly earnings results on Thursday. The basic materials company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.34 by $0.16. The company had revenue of $8.80 billion during the quarter, compared to analysts’ expectations of $9.54 billion. Vale had a net margin of 14.23%…

So oil is still at a relative 10 year low thanks to the fracking supply glut. And it just made me think… there's some good opportunities to be had in the current market. According to Joseph Schumpeter, businesses go in these sorts of cycles. A market grows and booms, and in that boom, many competitors…